Status:
COMPLETED
Development and Validation of a Symptom Scale for Children With Chronic Graft-versus-Host Disease
Lead Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborating Sponsors:
University of Minnesota
Dana-Farber Cancer Institute
Conditions:
Graft vs Host Disease
Eligibility:
All Genders
5-18 years
Brief Summary
Chronic Graft-versus-Host Disease (cGVHD) is an important cause of morbidity and mortality in patients undergoing allogeneic bone marrow transplantation. cGVHD usually occurs after 100 days following ...
Detailed Description
A large number of children with cGVHD have to deal with many years of a disfiguring and painful chronic illness with the side effects of long term steroid use. The number of stem cell transplants done...
Eligibility Criteria
Inclusion
- 5-18 years of age
- Prior allogeneic Stem Cell Transplant, with any graft source, donor type, and GVHD prophylaxis allowed
- Clinical diagnosis of cGVHD
- Need for systemic treatment, defined as any medication or intervention delivered
- No evidence of primary disease relapse
- Signed, informed consent, and if applicable, adolescent assent
Exclusion
- Inability to give signed informed consent
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00632658
Start Date
January 1 2008
End Date
July 1 2011
Last Update
October 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States, 60611